Lol right?
So the authors (MSB et al.) who have a huge financial and reputational incentive, state that the best the data is is hypothesis generating.
Is the company now downramping too? Maybe science is downramping!
Because what I've said is... hold on.... the same thing. And the expert panel? Also the same thing.
So why's the hated being directed at those that are right? Is it better to be wrong yet blissful?
Cell Therapy News/Articles, page-17128
-
- There are more pages in this discussion • 693 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |